ReviewFoods (Basel, Switzerland)2026
Food and Medicine Homology Substances as Potential Modulators of the Gut-Muscle Axis in Animal Meat Quality: A Review.
Review in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrative Multi-Omics Analysis Reveals Germplasm Advantages and Candidate Mechanisms Underlying High Intramuscular Fat Deposition in Wuhuang Pigs.Foods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Food and medicine homology (FMH) substances are increasingly utilized as nutritional and medicinal resources in sustainable livestock production. Their active ingredients include polysaccharides, flavonoids, and terpenes, which may positively affect livestock meat quality by maintaining gut microbiota homeostasis, enhancing intestinal barrier function, and facilitating nutrient absorption, as well as regulating key signaling pathways such as mechanistic target of rapamycin (mTOR), AMP-activated protein kinase (AMPK), and nuclear factor-κB (NF-κB). Notably, the meat quality improvement can also be indirectly achieved via the gut-muscle axis. Gut microbiota metabolites, including short-chain fatty acids (SCFAs), bile acids (BAs), and amino acid derivatives, modulate microbial homeostasis, intestinal barrier function, and nutrient absorption through the gut microbiota-metabolite axis, gut-immune axis, and nutrient absorption-signaling axis. These processes remotely regulate skeletal muscle metabolism, inflammation, and fiber type transformation, ultimately influencing meat tenderness, flavor, juiciness, and nutritional value. Despite their potential to reduce reliance on antibiotic growth promoters and enhance meat quality, multiple challenges persist, including complex component profiles, elusive mechanisms, undefined dose-effect relationships, inadequate standardization, insufficient safety evaluation and scarce direct trials on livestock meat quality endpoints. This review summarizes FMH substances that modulate the gut-muscle axis in meat quality regulation across different animal species and outlines their application prospects, aiming to facilitate antibiotic-free agriculture, the development of green functional feeds, and sustainable animal husbandry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.